What is Rti?
Headquartered in Brookings, South Dakota, RTI, LLC operates as a premier veterinary contract research organization (CRO) with a legacy dating back to 1994. The company serves as a vital link in the biopharma and advanced nutrition supply chains, providing comprehensive support for pre-clinical and clinical research, diagnostics, and complex regulatory affairs. Their expertise spans specialized domains including pharmacology, vaccinology, and immunology, all conducted under strict GLP and GCP compliance. As a trusted partner for global entities, RTI, LLC bridges the gap between laboratory innovation and real-world health outcomes, ensuring that animal health products meet the highest safety and efficacy benchmarks required by international regulatory bodies.
How much funding has Rti raised?
Rti has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Rti
PPP
Public-Private Partnership
What's next for Rti?
With this late-stage capital injection, RTI, LLC is poised to scale its infrastructure and expand its research capabilities to meet the evolving demands of the global health and welfare sectors. The strategic deployment of these funds will likely focus on enhancing diagnostic throughput and deepening the firm's technical bench in immunology and vaccine development. As the biopharma industry continues to prioritize high-quality, compliant research, RTI, LLC is strategically aligned to capture increased market share. Future growth will likely be driven by the integration of advanced analytical technologies and the expansion of their clinical trial footprint, further cementing their status as an indispensable partner for developers of advanced animal nutrition and therapeutic solutions.
See full Rti company page
